Mycobacterium avium complex and Mycobacterium kansasii

被引：0
作者：
Fisher, M. [1 ]
Ong, E. [2 ]
Pozniak, A. [3 ]
机构：
[1] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England
[2] Newcastle Gen Hosp, Newcastle Upon Tyne, Tyne & Wear, England
[3] Chelsea & Westminster Hosp, London, England
来源：
HIV MEDICINE | 2011年 / 12卷
关键词：
Mycobacterium avium complex (MAC); Mycobacterium kansasii; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECONSTITUTION DISEASE; ACTIVE ANTIRETROVIRAL THERAPY; BONE-MARROW EXAMINATION; HIV-INFECTED PATIENTS; RANDOMIZED-TRIAL; DOUBLE-BLIND; RAPID IDENTIFICATION; MAINTENANCE THERAPY; COMBINATION THERAPY;
D O I：
10.1111/j.1468-1293.2011.00944_9.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：75 / 82
页数：8
相关论文
共 61 条
[1]   A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex:: AIDS Clinical Trial Group 393 Study Team [J].
Aberg, JA ;
Williams, PL ;
Liu, T ;
Lederman, HM ;
Hafner, R ;
Torriani, FJ ;
Lennox, JL ;
Dube, MP ;
MacGregor, RR ;
Currier, JS .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (07) :1046-1052
[2]   Localized osteomyelitis due to Mycobacterium avium complex in patients with human immunodeficiency virus receiving highly active antiretroviral therapy [J].
Aberg, JA ;
Chin-Hong, PV ;
McCutchan, A ;
Koletar, SL ;
Currier, JS .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (01) :E8-E13
[3]   A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome [J].
Benson, CA ;
Williams, PL ;
Currier, JS ;
Holland, F ;
Mahon, LF ;
MacGregor, RR ;
Inderlied, CB ;
Flexner, C ;
Neidig, J ;
Chaisson, R ;
Notario, GF ;
Hafner, R .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1234-1243
[4]   Incidence and clinical implications of isolation of Mycobacterium kansasii:: Results of a 5-year, population-based study [J].
Bloch, KC ;
Zwerling, L ;
Pletcher, MJ ;
Hahn, JA ;
Gerberding, JL ;
Ostroff, SM ;
Vugia, DJ ;
Reingold, AL .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (09) :698-+
[5]   Mycobacterium kansasii disease in patients infected with it human immunodeficiency virus [J].
Campo, RE ;
Campo, CE .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1233-1238
[6]   Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection [J].
Chaisson, RE ;
Keiser, P ;
Pierce, M ;
Fessel, WJ ;
Ruskin, J ;
Lahart, C ;
Benson, CA ;
Meek, K ;
Siepman, N ;
Craft, JC .
AIDS, 1997, 11 (03) :311-317
[7]   CLARITHROMYCIN THERAPY FOR BACTEREMIC MYCOBACTERIUM-AVIUM COMPLEX DISEASE - A RANDOMIZED, DOUBLE-BLIND, DOSE-RANGING STUDY IN PATIENTS WITH AIDS [J].
CHAISSON, RE ;
BENSON, CA ;
DUBE, MP ;
HEIFETS, LB ;
KORVICK, JA ;
ELKIN, S ;
SMITH, T ;
CRAFT, JC ;
SATTLER, FR ;
STOOL, EW ;
MACGREGOR, RR ;
BUEHNER, T ;
WU, AW ;
BARNES, GL ;
BECKER, R ;
URBANSKI, P ;
RICHARDSON, W ;
HAFNER, R ;
DIXON, D ;
FEIGAL, DW ;
DELLERSON, M ;
GUPTA, S ;
HENRY, D ;
SCHLAGER, S .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :905-911
[8]   MYCOBACTERIUM-AVIUM COMPLEX IN THE RESPIRATORY OR GASTROINTESTINAL-TRACT AND THE RISK OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
CHIN, DP ;
HOPEWELL, PC ;
YAJKO, DM ;
VITTINGHOFF, E ;
HORSBURGH, CR ;
HADLEY, WK ;
STONE, EN ;
NASSOS, PS ;
OSTROFF, SM ;
JACOBSON, MA ;
MATKIN, CC ;
REINGOLD, AL .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :289-295
[9]   TREATMENT OF DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS WITH AMIKACIN, ETHAMBUTOL, RIFAMPIN, AND CIPROFLOXACIN [J].
CHIU, J ;
NUSSBAUM, J ;
BOZZETTE, S ;
TILLES, JG ;
YOUNG, LS ;
LEEDOM, J ;
HESELTINE, PNR ;
MCCUTCHAN, JA .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (05) :358-361
[10]   A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients:: Excess mortality associated with high-dose clarithromycin [J].
Cohn, DL ;
Fisher, EJ ;
Peng, GT ;
Hodges, JS ;
Chesnut, J ;
Child, CC ;
Franchino, B ;
Gibert, CL ;
El-Sadr, W ;
Hafner, R ;
Korvick, J ;
Ropka, M ;
Heifets, L ;
Clotfelter, J ;
Munroe, D ;
Horsburgh, CR .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (01) :125-133
1234567